Ligand · 417
417 · (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine
417, (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine (C18 H19 F6 N5, 419.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- 417
- Formula
- C18 H19 F6 N5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
417 in 2 structures; the first of them:
- 2P8S · Human dipeptidyl peptidase IV/CD26 in complex with a cyclohexalamine inhibitor · 417 A1001 · binds ARG125, HIS126, GLU205, GLU206, SER209, PHE357, ARG358, TYR547 and 9 more
- 2P8S · Human dipeptidyl peptidase IV/CD26 in complex with a cyclohexalamine inhibitor · 417 A1001 · binds ARG125, HIS126, GLU205, GLU206, SER209, PHE357, ARG358, TYR547 and 9 more
Residues it binds most
TYR 4, GLU 4, HIS 4, SER 4, VAL 4, ARG 4, ASN 4, PHE 4, TRP 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.